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The expanding knowledge base regarding the pathophysiology, 
molecular biology, epidemiology and economic aspects of 
atherosclerotic cardiovascular disease provides a solid founda- 
tion for the development of guidelines for risk factor manage- 
ment. Randomized, controlled clinical trials have demonstrated 
the efficacy of a variety of interventions in the secondary 
prevention of coronary disease and in the primary prevention 
of disease in high risk individuals. The evidence and support of 
these interventions was felt sufficient o provide a consensus 
statement, endorsed by the American Heart Association and 
the American College of Cardiology, for the secondary pre- 
vention of coronary artery disease (1). 
However, the development ofa scientific rationale through 
basic and clinical studies often fails to influence clinical prac- 
tice. Convincing results of randomized clinical trials and widely 
disseminated guidelines often fall short of implementation 
(2-7). 
The existence of barriers to the implementation of risk 
reduction interventions appears obvious. Preventive services, 
including counseling, are provided less often than experts 
recommend and less frequently than patients and their physi- 
cians prefer (8). In a primary care setting, 75% of patients who 
smoke say they would attempt to stop smoking if their physi- 
cian advised them to do so, yet only 40% to 55% report that 
their physician provided such advice to them (9,10). Only 45% 
to 65% of patients with hypercholesterolemia hadevidence of 
treatment (3,11,12). The extent o which interventions recom- 
mended by the American College of Cardiology (1) are being 
carried out is poorly described. Table 1 shows estimates of the 
levels of risk factor management. These estimates deal only 
with initiation of any risk factor management; levels of ade- 
quacy of risk factor control could likely be much worse. 
Barriers that prevent hese efficacious and cost-effective inter- 
ventions from being deployed could be targetted as a way to 
correct deficiencies in levels of risk factor management. The 
objective of this task force report is to identify barriers within 
health care organizations which impede the provision of 
preventive services. Health care organizations under consider- 
ation range from primary care and cardiovascular specialty 
practices to hospitals, managed care organizations and third- 
party payors. Opportunities and strategies for these organiza- 
tions are then identified and evaluated as to their ability to 
effectively, feasibly and appropriately influence the provision 
of preventive cardiovascular services. Finally, a list of recom- 
mendations for organizations has been developed, based on 
the recognized needs of patients and providers and the pub- 
lished evidence supportive of the efficacy of specific strategies. 
Barriers to Implementation of Preventive 
Services: An Overview 
A variety of barriers to the successful implementation of
preventive services have been identified (Table 2). These 
include factors at the patient, provider, health care organiza- 
tion and community/societal levels (11,12). These different 
types of barriers might be considered sequential, in that any 
one barrier in the chain could result in a lack of provision of 
preventive service. 
Patient factors. A detailed discussion of patient factors is 
beyond the scope of this task force report. Physicians fre- 
quently perceive patients as not motivated or noncompliant, 
yet patients consistently report preventive services as a high 
priority for their health care and want physicians to provide 
life-style and prevention recommendations. Ironically, patients 
cite physicians's failure to order tests, give information or com- 
municate results as reasons not to request preventive services 
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Table 1. Estimates of Levels of Risk Factor Management i  
Patients Surviving Myocardial Infarction 
Referral to cardiac rehabilitation program* 
Smoking cessation counselingt 
Lipid-lowering drug therapy'¢ 
Beta-blocker therapyt 
ACE inhibitor therapy (reduced LV ejection fraction)t 
Aspirint 
<5% 
20% 
25% 
40% 
60% 
70% 
*Coronary Artery Surgery Study (CASS): a randomized trial of coronary 
artery bypass urgery. Quality of life in patients randomly assigned to treatment 
groups. Circulation 1983;68:951-60. tVogel RA. Risk factor intervention and 
coronary artery disease: clinical strategies. Coronary Artery Dis 1995;6:466-71. 
~Pearson TA, personal communication, September 1995. ACE = angiotensin- 
converting enzyme; LV - left ventricular. 
(8). Patient demand for service remains the most powerful 
determinant of whether a physician addresses a patient's 
problem (8), so empowerment of patients to seek preventive 
services remains aviable strategy to influence physician behav- 
ior. Blaming the patient does not spare the patient's care. Lack 
of optimization of patient compliance by the physician or 
health care organization in the final analysis only serves to 
reduce the effectiveness of the risk factor management. An 
active role for family members in the patient's compliance 
cannot be overemphasized (13). 
Physician harriers. Primary care physicians and cardiovas- 
cular specialists share a variety of constraints, including a 
fundamental focus on acute problems, coupled with limited 
time to carry out additional assessments and interventions 
other than those acutely indicated. The practicing cardiologist 
faces increasing time commitments to acute hospital care, 
Table 2. Barriers to Implementation of Preventive Services 
Patient 
Lack of knowledge and motivation 
Lack of access to care 
Cultural factors 
Social factors 
Physician 
Problem-based focus 
Feedback on prevention is negative or neutral 
Time constraints 
Lack of incentives, including reimbursement 
Lack of training 
Poor knowledge of benefits 
Perceived ineffectiveness 
Lack of skills 
Lack of specialist-generalist communication 
Lack of perceived legitimacy 
Health care settings (hospitals, practices, etc.) 
Acute care priority 
Lack of resources and facilities 
Lack of systems for preventive services 
Time and economic onstraints 
Poor communication between specialty and primary care providers 
Lack of policies and standards 
Community/society 
Lack of policies and standards 
Lack of reimbursement 
interventional procedures and pressure by managed care con- 
tracts to see outpatients during shorter, highly focused visits 
that provide little time for preventive care. The very nature of 
risk factor interventions provides neutral feedback, which, in 
the setting of the patient's complaint or side effects, can be 
negative. Finally, the immediate gratification from a patient's 
improvement after an acute intervention is reinforced by better 
reimbursement for acute care services and procedures, in 
contrast o the less acute management of risk factors, which 
has traditionally been poorly reimbursed. 
Lack of training and confidence are frequently cited as 
major barriers to physician use of preventive strategies (12,14,15). 
Physicians report general awareness of practice guidelines, 
but limitations in training, skills and experience prevent treat- 
ment approaches for risk factor reduction from being carried 
out. A recent survey of primary care physicians indicated that 
69% of these physicians considered themselves confident o 
provide smoking cessation counseling, but only 32% felt 
confident about dietary counseling, and 36% felt confident 
using medications for cholesterol (16). Likewise, cardiologists 
are generally not well educated in nutrition counseling or the 
nuances of lipid-lowering agents (17). Most cardiology training 
programs do not have specialists in lipid disorders or risk factor 
management asmembers of the cardiology division, resulting 
in the majority of training programs in cardiology providing 
inadequate ducational experiences in preventive cardiology. 
Thus, knowledge of benefit, perceived effectiveness and skills 
are often acknowledged by cardiovascular specialists and pri- 
mary care physicians alike as barriers to the practice of risk 
factor reduction. 
The interface between primary and specialty care of the 
patient with coronary disease is another area where the chain 
of preventive care is often disrupted. Treatment recommenda- 
tions for patients hospitalized for myocardial infarction fre- 
quently do not include risk factor management recommenda- 
tions provided by the cardiovascular specialist, suggesting to 
the generalist that these interventions are not important (18). 
Cardiologists and cardiac surgeons may not perceive that risk 
factor management is their responsibility. Some interventional 
cardiologists and surgeons fear loss of patient referral should 
they interfere with this management, which may be considered 
the domain of the generalist. Thus, the absence of perceived 
legitimacy in this area by the specialist results in the interpre- 
tation of risk reduction interventions as being irrelevant by the 
generalist. Clearly, the specialist and generalist need to sup- 
port each other's efforts to provide a consistent and strong 
recommendation forthe management of risk factors. However, 
the cardiovascular specialist must ensure optimal care of the 
patient with vascular disease ither by emphasizing the need 
for risk factor management bythe primary care provider or by 
providing those services himself or herself. 
Organizational barriers. Primary care and specialty prac- 
tices, hospitals and managed care organizations may provide 
obstacles to even well trained, skillful physicians and their 
motivated patients. Although there are many barriers to the 
implementation f services for cardiovascular risk reduction in 
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primary care and specialty care settings, the hospital poses 
particular barriers to the provision of these services. Providing 
risk factor management in a hospital setting is complicated by 
at least three factors: 1) the environment of the hospital itself 
poses logistic problems; 2) no system or infrastructure exists to 
enable health care professionals to focus on prevention; and 
3) there is a lack of reimbursement for hospital-based preven- 
tive services (see next section). 
The hospital setting itself poses unique problems. Even 
among patients hospitalized for conditions related to risk 
factors, such as smoking, hypertension or hyperlipidemia, the 
focus of hospitalization is not on risk factor management. 
Rather, the focus is on the acute condition prompting the 
hospital admission. In addition, there is a limited amount of 
time during the hospital period to interact with patients 
because of the pressure for early hospital discharge. Patients 
are often in pain or undergoing multiple procedures during 
this period. Although most health care professionals recognize 
the need for education to begin within this setting, the acuity of 
hospital care is increasing, which renders patients less recep- 
tive and capable of internalizing information provided uring 
the hospital period. 
The second major problem within the hospital setting is the 
lack of infrastructure or resources, facilities, staff and system 
organization to allow health care professionals tofocus on risk 
factor management. Although education is sometimes pro- 
vided by multidisciplinary groups, such as physicians, nurses, 
nutritionists, respiratory and physical therapists and pharma- 
cists, roles and responsibilities for providing specific content 
are often not well specified. To enable health care profession- 
als to interact successfully, clear lines of communication, 
coordination and prioritization must be established. Lines of 
responsibility are often ambiguous in hospital settings when 
patients are seen by house staff and multiple specialists as well 
as, or in lieu of, the primary care providers. Staff nurses, the 
most numerous health care providers within this setting, focus 
on the management of the patient's acute condition, not 
rehabilitation or risk factor management. Few nurses, physi- 
cians or other health care professionals have undergone formal 
training in the behavioral aspects of management that underlie 
risk factor modification, nor is there a standard of performance 
that is expected of all health care professionals. Moreover, 
there is a lack of appropriate, ffective training materials to 
educate professionals in order to facilitate risk factor modifi- 
cation. Although numerous health education materials have 
been developed both commercially and through nonprofit 
organizations, they are oftentimes too general to be of help to 
patients, they are perceived as costly, and few have undergone 
extensive evaluation. Finally, the hospital setting does not 
provide for systematic follow-up of patients, which is essential 
to the maintenance ofrisk factor changes. This discontinuity in
care is due to the fact that most hospital-based staff do not 
interact with patients and their primary care providers after 
hospital discharge. 
External barriers. Until recently, data regarding reduction 
of morbidity and mortality from risk factor modification have 
been lacking, thereby causing cardiologists o defer its imple- 
mentation (1,13). The lack of clear standards for preventive 
services continues to confuse generalists and specialists alike. 
The lack of reimbursement for risk factor management is 
shared as a barrier to providing such care by primary care, 
outpatient cardiology and hospital-based services. Health care 
professionals have not traditionally been paid to provide 
preventive services. The financial focus on acute care rather 
than preventive care reduces the likelihood of designation of 
positions and commitment of resources and personnel by 
health care organizations. Ironically, funding mechanisms to 
support counseling by nurses and nutritionists are generally 
not well understood by physicians, thus these individuals are 
not utilized by most physicians in their practices due to 
perceived financial disincentives. 
Efficacy, Effectiveness and Feasibility of 
Strategies to Improve the Organization of 
Preventive Services 
Interventions by Physicians 
Physician education programs. The training and certifica- 
tion of cardiovascular specialists hould include all the require- 
ments for 1) knowledge of the pathophysiologic roles of the 
risk factors and the evidence from epidemiologic studies and 
clinical trials supporting their association with vascular disease; 
2) the ability to comprehensively assess individual risk factors 
and overall risk; and 3) skills to modify risk factors using both 
nonpharmacologic and pharmacologic nterventions. Current 
training programs may need to add these areas to their 
curricula to ensure organization of required information (19). 
The increased role of the cardiovascular specialist may identify 
new manpower needs in the current climate in which specialists 
with procedural skills are in oversupply and in which cognitive 
noninvasive and risk reduction skills are being increasingly 
employed (19). 
Although approximately $3 billion is expended yearly on 
continuing medical education (CME) programs in the United 
States, their impact on physician performance and patient 
outcome remains uncertain (20,21). Five characteristics of 
successful CME programs are 1) identification of a specific 
target audience and learning need, 2) clear expression of 
learning objectives, 3) targeting a physician's clinical perfor- 
mance rather than knowledge, 4) implementation i  clinical 
settings, and 5) ability to measure change in physician practice 
(21). L1 contrast, dissemination of information using tradi- 
tional lectures, mass media and mailed material-based uca- 
tional strategies has been unsuccessful (22,23). In the preven- 
tive cardiology arena, Browner et al. (24) reported that 
physician compliance with recommendations of the National 
Cholesterol Education Program Expert Panel was not im- 
proved by intensive CME. More effective ducational strate- 
gies use reminders to the physician, educational sessions 
involving patients, outreach visits, the use of opinion leaders 
and multifaceted activities (22). Lamas et al. (25) demon- 
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strated a measurable influence of the dissemination of re- 
sults of randomized clinical trials concerning the use of aspirin 
and calcium channel blockers on the management of patients 
with myocardial infarction. These results and similar reviews 
(26,27) support the concept hat CME, when based on the 
results of clinically relevant, well conducted, randomized trials, 
rather than panel-generated guidelines, may have a significant 
impact on physician practice patterns. The majority of studies 
involving CME suggest hat these efforts are frequently inef- 
fective unless they are performed in combination with medical 
record audits and individualized feedback to practitioners 
about deviations from practice standards. 
Consensus tatements/clinical guidelines. During the past 
decade, a variety of organizations involved with health care, 
including professional societies, private consulting firms, gov- 
ernmental bodies and managed care groups, have developed 
guidelines and consensus statements for patient care. The basis 
for these guidelines and statements range from the results of 
large randomized, controlled trials to expert panel opinion. 
The impact of guidelines on patient care and outcomes re- 
mains unestablished (2). Although awareness with guidelines 
may be as high as 60% within 1 year of release, actual 
compliance may be quite low (23). In earlier studies, Brooks 
(28) found only 15% compliance with American Heart Asso- 
ciation guidelines on antibiotic prophylaxis for endocarditis. In
a study involving low risk patients admitted to coronary care 
units, compliance with guidelines for chest pain management 
was higher by internists (84%) than cardiologists (53%) (7). 
Studies demonstrate a much higher acceptance rate of guide- 
lines by subspecialists when they are developed by their own 
subspecialty organizations (29). Thus, in one review (30), 80% 
of cardiologists showed evidence of awareness with American 
College of Cardiology guidelines for exercise testing in con- 
trast with a 29% awareness with those of the American College 
of Physicians. Although physicians may be aware of guidelines, 
the ultimate impact on practice patterns i  highly debated. The 
NIH Consensus Development Conference (31) failed to show 
evidence that recommendations on coronary artery bypass 
graft surgery affected practice patterns. Lomas et al. (32) 
concluded that guidelines may be effective in persuading 
physicians to alter their practice patterns, but without incen- 
tives or removal of disincentives, guidelines were not likely to 
change actual clinical practice. In a review on the effect of 
clinical guidelines in medical practice, Grimshaw and Russell 
(33) emphasized that success of guidelines i multifactorial nd 
dependent on methods of development, dissemination and 
implementation. They concluded that explicit guidelines do 
improve clinical practice when introduced into the context of 
rigorous evaluations. 
Finally, the importance of nonphysician parameters in the 
successful implementation f guidelines cannot be overempha- 
sized. Ellrodt et al. (34) noted that physician refusal accounted 
for a small percentage (16%) of noncompliance with chest pain 
guidelines and emphasized that implementation issues, health 
care system inefficiency and severity of illness were the pre- 
dominant reasons for physician noncompliance with these 
guidelines. 
Performance feedback. Feedback is a mechanism by which 
individuals can receive information to shape and perfect heir 
behavior through successive approximations (35). Most feed- 
back has been centered on physician performance based on 
medical record audits (36) or physician knowledge assessment 
(37). The mechanisms of feedback include group discussion, 
personalized written feedback, computer-generated f edback 
or one-on-one discussion (36-42). In general, the more per- 
sonalized the feedback, the greater the impact on physician 
practice (22). Feedback which also includes educational meth- 
ods and pertinent information seems to add to the effective- 
ness. In one study (42), performance feedback exceeded a
reminder system in its effectiveness in changing medical house 
staff cholesterol management practices in inpatients with cor- 
onary disease. 
Interventions by Nurses and Other Professionals 
Nursing education programs. Postgraduate education pro- 
grams have increased the knowledge base of health care 
professionals in the area of risk factor modification, but too 
often these programs are not tied to a designated service role. 
For example, initiatives such as the National Cholesterol 
Education Program for Nurses have been undertaken by the 
American Heart Association to expand the knowledge and 
expertise of nurses in managing the dietary and drug aspects of 
hyperlipidemia. However, for many of those who undergo this 
training, there is no job waiting which would enable them to 
implement heir expertise in a practice setting. As stated 
earlier, education alone will not solve the problem of inade- 
quate service delivery in hospital or ambulatory care settings. 
Organizational issues such as staffing and reimbursement have 
to be resolved before the nurses' special training can be 
harnessed to affect clinical delivery of preventive services. 
Nursing standards/clinical guidelines. Organizations such 
as the American Nurses Association have long been involved 
in defining the scope of nursing practice, through the develop- 
ment of standards and clinical guidelines. While these stan- 
dards have been well delineated for such areas as critical care, 
medical/surgical nursing and recently cardiac rehabilitation 
(43), nursing standards and guidelines for risk factor modifi- 
cation have not yet been defined. The reluctance of organiza- 
tions such as the American Nurses Association to develop 
sufficiently effective and broad-based guidelines that ensure 
the delivery of risk factor modification is most likely due to a 
lack of defined role and reimbursement for nurses to perform 
these services. The problems of implementing clinical guide- 
lines are also very similar to those for physicians. These include 
the following: 1) Guidelines are by necessity general, whereas 
the needs of the patients are highly specific; 2) a large amount 
of time is required to develop consensus guidelines that quickly 
become outmoded, and which may be difficult to assess in a 
clinical setting; 3) although nurses are able to implement 
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directives and management protocols, they, like physicians, 
want autonomy to carry out their roles. 
Supportive educational materials, Educational materials 
have been developed by numerous organizations, such as the 
National Heart, Lung, and Blood Institute and the American 
Heart Association, to help health care professionals in the 
areas of risk factor modification. While training materials or 
direct education pamphlets or brochures increase knowledge 
and promote awareness for both the health care professional 
and the patient, to be effective they must have a behavioral 
basis. Most of these materials have not incorporated self- 
efficacy theory, targeted goals and feedback (44), nor have they 
taken into account the educational nd cultural background of 
the health care professional or the patient. Many hospitals 
have developed "home-grown" materials, believing that avail- 
able materials did not suit their patient population. Merely 
keeping track of these materials and making them available to 
all patients is often taxing. Large demand for high quality 
education materials would spur commercial development, but 
to date this demand appears to be modest. 
Nurse case-management programs, Nurse case-management 
programs have begun to address the organizational nd staffing 
barriers to implementation f preventive services noted earlier. 
These programs have generally been implemented in the 
managed care setting, which provides the proper incentives to 
program implementation. However, even in a managed care 
setting, the widespread issemination of these programs ulti- 
mately depends on financial considerations, including the 
short-term costs incurred in the first few months to years of 
implementation. Some managed care organizations remain 
unaware or unconvinced of these programs' benefits, and are 
not willing to bear these costs. Moreover, this problem is 
exacerbated bythe tendency of patients to leave managed care 
plans before the investment in their health care can be 
recouped. 
Case-management systems for risk factor modification are 
not only more efficacious, but are generally more cost-effective 
than physician-mediated risk factor modification. This greater 
cost-effectiveness is due to the lower salaries of nurses, but in 
addition, some systems rely more heavily on phone and mail 
contact han face-to-face visits. Nurses, therefore, can be hired 
and trained to devote themselves to this one activity, whereas 
physicians attempt o devote themselves to a broad range of 
activities, only some of which concern risk factor modification. 
The same elements of case management that contribute to 
cost-effectiveness al o contribute to convenience for patients 
and increased patient satisfaction. 
Managing cardiovascular risk factors is a complex, multi- 
factorial process. It involves not only educating patients and 
helping them develop skills to change and maintain multiple 
health behaviors, but also increasing their adherence to med- 
ication regimens and teaching them to initiate appropriate 
action in response to the development of drug side effects 
or worsening of cardiac symptoms. Nurses have shown con- 
siderable expertise in facilitating long-term monitoring of 
hypertension (45), diabetes (46), smoking cessation (47) and 
lipid-lowering drug therapy (48). Moreover, when a nurse case- 
management approach as been applied to patients recovering 
from myocardial infarction, nurses have shown a high degree 
of efficacy in managing multiple risk factors (49). This case- 
management system documented a reduction in plasma low 
density lipoprotein (LDL) cholesterol among post-myocardial 
infarction patients to 107 mg/dl, which is close to the bench- 
mark value established for regression of atherosclerotic lesions 
and a reduction of clinical events (1). 
What accounts for the efficacy of case management for 
coronary risk factor modification and coronary disease risk 
management? Whether managing diabetes or hypertension, 
which predispose the patient to coronary artery disease, or 
managing multiple risk factors, nurses achieve three important 
objectives: 1) increasing patients' adherence to drug and diet 
regimens; 2) instructing patients in self-monitoring of weight, 
blood pressure, symptoms, blood glucose or smoking relapse; 
and 3) teaching patients to take appropriate action in response 
to new or worsening symptoms. The system for coronary risk 
factor modification can also be well integrated into the usual 
care provided to patients. It uses existing facilities (e.g., 
hospital wards or outpatient clinics) for a baseline visit and 
convenient channels of communication (e.g., the telephone 
and mail) for follow-up of patients. Nurse case managers' 
telephone contacts with patients provide an important mea- 
sure of surveillance, instruction and support. Primary care 
physicians can also be kept abreast of their patients' medical 
conditions by phone and mail. In addition, standardized algo- 
rithms and the use of a computerized data base facilitate data 
management and assist nurses in medical decision making. Use 
of such a system contributes to the standardization f care and 
the assessment of quality. Nurse case-management systems 
appear to have particularly great appeal, in as much as they are 
well integrated into the medical care system, offer a measure of 
patient surveillance and a high degree of satisfaction and result 
in significant cost savings. 
Interventions in Health Care Institutions 
(Hospitals, Clinics, Practices) 
Centralized identification of patients by laboratories, clin- 
ical units and pharmacies. Various forms of cues or remind- 
ers have been used to identify patients in need of preventive 
services. These cues have ranged from chart-attached remind- 
ers and nurse-prepared checklists to computer prompts. Ob- 
scuring abnormal aboratory data on laboratory reports of 
inpatients with fluorescent tape improves physician attention 
to the abnormal values (50). Cholesterol values identified as 
abnormal by the laboratory computer were more likely to lead 
to follow-up treatment than those values not described as 
abnormal (51). Reminder checklists affixed to outpatient 
records prompted increased preventive care (52,53). Mc- 
Donald (54) used computer-generated preventive care remind- 
ers, showing that preventive services of 126 physicians were 
20% higher when cued. Similarly, nurse-generated checklists 
led to a 17% to 22% increase in preventive services (55-57). 
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Weingarten et al. (7) demonstrated that the use of guidelines 
for patients with low level chest pain was increased from 50% 
to 69% through the use of prompting with a structured 
message pasted on patients' charts which summarized the 
patient's risk and the guideline recommendations. Although 
the reminders were present for nearly 1 year, their removal was 
associated with frequent failure of physicians to comply with 
guideline recommendations. In general, cue and reminder 
systems appear to improve the implementation f preventive 
services, possibly assisting the physician to consider preventive 
care even in the acute care setting. 
More sophisticated computer-based clinical decision mak- 
ing and clinical support systems have had more variable levels 
of success. Johnston et al. (58) have reported on the use of 
computer-based clinical support systems, concluding that their 
success was variable but noting improved physician perfor- 
mance in four of six studies designed to enhance the quality of 
preventive care. Using low level, noncoercive information 
without direct human contact, Lee et al. (59) showed no effect 
on management of patients with chest pain. Their study 
involved low risk patients, and they noted in a subset hat 
physicians were more likely to consult decision aids for higher 
risk patients, suggesting that an important parameter in the 
effective use of decision aids may be the physicians' attitudes 
about which patients are appropriate to treat and when they 
need assistance. Another strategy is the organization of "crit- 
ical pathways," in which a comprehensive approach to a 
clinical problem is developed and carried out on establishment 
of a diagnosis. 
Monitoring systems. Monitoring systems provide data for 
individual and organizational feedback and reinforcement, and 
improve the potential for success (60). Computerized record 
systems facilitate quality assurance and management efforts to 
provide performance data and to reinforce organizational nd 
provider behavior. 
Referral clinics with subspecialty services. Many now be- 
lieve that guidelines require utilization of physician or health 
care teams with special expertise for optimal results. Lomas et 
al. (32) have studied the effectiveness ofphysician team leaders 
nominated by their colleagues as a method of enhancing 
guideline ffectiveness, demonstrating a significant increase in 
the implementation a d outcomes in comparison to combined 
audit and feedback methods. Although improved, the compli- 
ance rate with guidelines after 4 years was no better than 70%, 
suggesting the need for additional strategies. There is now a 
growing appreciation for the impact of the physician-nurse 
case-management team approach in the implementation of
risk factor modification guidelines. DeBusk et al. (49) have 
demonstrated substantial improvements in modification of 
coronary risk factors after myocardial infarction using specially 
trained nurses to initiate smoking cessation, exercise training 
and diet-drug therapy for hyperlipidemia in the hospital. After 
discharge, telephone and mail contact were utilized to imple- 
ment intervention. They concluded that in the large health 
maintenance organization, this case-management system was 
considerably more effective than the usual medical care for 
modification of risk factors after myocardial infarction. In 
some current managed care organizations or those using 
capitated care, a team approach with care provided by a 
nonphysician provider may allow for additional visits than 
those allowed under other reimbursement systems. 
Interventions in Health Care Systems and 
Third-Party Payors 
Quality assurance programs and standards. Quality assur- 
ance is defined as "the measurement of the actual level of 
quality of services rendered, plus the efforts to modify when 
necessary the provision of these services in the light of the 
results of the measurement" (51). Quality assurance programs 
are readily applicable to primary and secondary preventive 
care programs and may have three phases (61): 1) Explicit 
acute and preventive care criteria are based on results of 
epidemiologic research and controlled clinical trials. To date, 
these criteria for risk factor management have not been 
finalized. 2) Clinical researchers document the levels of per- 
formance of practitioners concerning levels of care, often 
identifying them as deficient (62) (Table 1). 3) The research 
then seeks to examine barriers to the implementation f the 
care standards (see Barriers to Implementation f Preventive 
Services: An Overview). 
An essential component of the quality assurance program is 
the feedback loop (63). This can take several forms, as noted 
previously, and can be tied to a variety of incentives, including 
financial rewards, credentialing or accreditation. One recently 
popular performance report on quality is the Report Card, 
such as that proposed by the Health Plan Employer Data and 
Information Set (HEDIS), for use by employers to evaluate 
and select managed care organizations (64). More specific 
performance r ports include risk-adjusted mortality rates for 
coronary artery bypass by hospitals and surgeons in New York 
State, as published in the lay press (65). Quality assurance 
reports are acknowledged to have a number of drawbacks 
(64,66), but will most likely continue to provide motivations to 
health care systems to self-examine their performance. 
Reimbursement policies. Reimbursement schedules ap- 
pear to influence work performance, specially in practicing 
physicians (67). Preventive services in inpatient and ambula- 
tory care settings have frequently not been reimbursed, pro- 
viding a major disincentive to providers and patients alike 
(11,68). As noted previously, inconsistent or absent reimburse- 
ment policies results in allocation of time, space, personnel and 
supplies directed away from preventive fforts toward acute 
care services. 
Legislation and regulations. Efforts to regulate or legislate 
health care have had mixed results, but provide the potential 
for maintenance of certain levels of quality of care (64). One 
example is the New York State Hospital-Based Coronary 
Prevention Program. As part of a Certificate of Need applica- 
tion for initiation or expansion of cardiac surgical or invasive 
cardiologic services, hospitals in New York State are required 
to submit a preventive cardiology plan for risk factor identifi- 
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cation and management in patients with coronary disease and 
their first-degree r latives, a heart disease prevention program 
for employees and involvement in community-based heart 
health programs. This program then ties risk reduction efforts 
to the ability to acquire additional acute care services, as an 
example of regulations which might encourage appropriate use 
of preventive services. Additional regulations in the areas of 
quality assurance, reimbursement and credentialing may also 
foster improved levels of care. 
Recommendat ions  
The overall recommendation f this task force and, indeed, 
this Bethesda Conference is that appropriate risk factor man- 
agement is a key part of the optimal care of the patient with 
established cardiovascular disease or the patient with high risk 
of developing the disease. Additional, more specific recom- 
mendations have been proposed as solutions to specific prob- 
lems identified in the organization of risk factor management 
services. They are as follows: 
1. Consensus statements, clinical guidelines and standards 
of care for preventive cardiology should be developed for use 
by practitioners and health care organizations by the American 
College of Cardiology in collaboration with other organiza- 
tions involved with ensuring the quality of care for cardiovas- 
cular disease. Examples include guidelines on hypertension 
management by the Joint National Committee Fifth Report 
(69), the National Cholesterol Education Program's Adult 
Treatment Panel Report (70) and the Guidelines on Cardiac 
Rehabilitation of the Agency for Health Care Policy Research 
(71). 
2. Research to identify, quantify and overcome the various 
barriers to implementation of clinical guidelines hould be 
performed. 
3. Lack of reimbursement or coverage for preventive car- 
diology services has been a disincentive to optimal risk factor 
management. Efficacious preventive cardiology services are 
those which should be reimbursed or covered, including care 
by nonphysician providers. 
4. Physician and nurse education programs hould empha- 
size clinically relevant material focusing on consensus tate- 
ments or clinical guidelines, or both, taking into consideration 
the needs of specific target audiences. Clear learning objec- 
tives, targeting clinical performance rather than knowledge, 
need to be established for implementation i  clinical settings, 
utilizing some form of feedback and positive performance 
evaluation. 
5. Health care organizations should set goals for imple- 
mentation of proven strategies for heart disease prevention, 
including the formation of alliances between reimbursement 
agencies, specialists and primary care providers. 
6. Preventive cardiology programs have been developed 
and shown to be effective in practices, hospitals and managed 
care organizations. These programs hould be modified, im- 
plemented and evaluated to meet patient and organizational 
needs at a local level. These programs may benefit from the 
Table 3. Key Measures for Quality of Preventive Care* 
t. Smoking status hould be documented in all patients with coronary or 
other vascular disease 
2. Organizations should have a smoking cessation program available for 
the smoking patient and his or her family 
3. All eligible patients hospitalized with coronary or other vascular 
disease should have documented the offer of physician advice and self- 
help materials to stop smoking 
4. All patients with coronary or other vascular disease should have a 
fasting lipoprotein profile documented at the appropriate time within 
the first 3 months after onset of disease, if the patient is deemed 
appropriate for diet or pharmacologic intervention 
5. All patients with coronary or other vascular disease should be offered, 
as documented in the medical record, nutritional evaluation and 
counseling at the time of diagnosis 
6. All patients with coronary or other vascular disease who have an LDL 
cholesterol level >130 mg/dl after nutritional therapy should be 
prescribed, as documented in the record, lipid-lowering pharmacologic 
therapy, if the patient is deemed appropriate for intervention 
7. All patients with coronary or other vascular disease should be assessed 
and provided with exercise counseling/prescription at the time of 
diagnosis, if the patient is deemed appropriate for intervention 
8. Aspirin therapy should be offered to all patients eligible at the time of 
diagnosis of coronary or other atherosclerotic disease. If aspirin 
therapy is not indicated, the contraindication should be documented in 
the medical record 
9. All patients with coronary or other vascular disease should have a 
blood pressure measurement documented atevery visit 
10. If an average of three blood pressure measurements is equal to or 
greater than 140 mm Hg diastolic or 90 mm Hg diastolic, life-style and 
pharmacologic therapy treatment plans should be offered and 
documented at the time of diagnosis 
*The risk reduction strategies as endorsed by the American Heart Associa- 
tion and American College of Cardiology should be implemented in patients 
with established cardiovascular disease. Some of these strategies can then be 
used to create key measures of risk factor management to monitor quality of 
care. 
utilization of nonphysician health professionals toprovide risk 
evaluation, intervention and follow-up. 
7. Quality assurance programs hould include risk factor 
management askey indicators of quality of care. A list of 10 
key indicators is proposed next as a starting point, recognizing 
that the list may evolve as new risk factors are established, as 
the effectiveness of new interventions becomes proven and as 
new methods to measure levels of risk factor management 
become implemented (Table 3). 
8. Reliable mechanisms to monitor the level to which 
clinical guidelines, practice standards and other goals in pre- 
ventive cardiology are being carried out should be developed 
and implemented. 
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